Drug pricing norms: Cost or MRP based?
As the second largest exporter of bulk drugs and largest formulation exporter, the Indian pharmaceutical industry has made its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Venus Remedies: Reinventing R&D
Generic dominated Indian pharma market also has exceptions like Venus Remedies who wants to make transition from generic to…
Regulatory woes of pharma SMEs (Part I)
Jagmohan Rai Agarwal has experienced the workings of the Indian drug regulatory authorities across the country while engaged in…
Back to the roots Landscaping OTC opportunities in the Indian ayurveda market
Sreedevi Yallamrazu, Senior Strategic Analyst, CubeX comments on the acceptance of traditional medicine for holistic health and…
A holistic view of the HPAPI opportunity
The High Potency Active Pharmaceutical Ingredients (HPAPI) segment is the potential cash cow of the pharma procurement basket but…
Beyond the Ban
The Government of India (GOI) recently banned the use of serology-based test kits for diagnosis of tuberculosis. But this will…
Sanofi ties up with Joslin Diabetes Center
Both parties will have access to intellectual property for internal research use
BoehringerLilly alliance to launch first diabetes drug in India
Boehringer Ingelheim India and Eli Lilly and Company India (Lilly), which represents the Boehringer Ingelheim – Lilly global…
CHMP recommends Novartis drug Afinitor for EU approval
To mark major milestone in the treatment of advanced breast cancer
Daiichi Sankyo and Ranbaxy launch hybrid business in Venezuela
The Venezuelan pharmaceutical market is the third largest in Latin America